Neuralink raised $650M in Series E funding. These funds will accelerate clinical trials & product development for their brain-computer interface (BCI). The goal is to restore autonomy for individuals with paralysis, speech/visual impairments. Currently, 5 patients with severe paralysis are using the device in global trials to control equipment with thoughts.
#crypto #blockchain #news
will with Series goal for paralysis control Currently, autonomy (BCI). equipment The clinical raised to are funds patients paralysis, the Neuralink to in individuals trials is thoughts.
#crypto 5 using in device restore funding. #blockchain trials severe & E #news with product interface brain-computer accelerate global their These development $650M speech/visual for impairments. with
